# India AMR Co-Development Programme (I-AMR-CDP)

> A translational and co-development pathway designed to identify and advance promising antibacterial innovations emerging from India. Led by Venus Remedies Limited.

AMR means antimicrobial resistance. The programme supports antibacterial therapeutics for human health in India through a project-specific co-development pathway. It is not an open-ended funding programme. Initial applications are non-confidential and use the external form linked in the programme guide.

The files below are generated from the website's own content. Eligibility, awards and support are conditional; refer to the published criteria and contact the programme team for decisions. Check the application form for current deadlines. Placeholder quotations are excluded from the Markdown mirror.

## Programme

- [Complete programme guide](/index.md): Purpose, eligibility, exclusions, stages, award conditions, IP terms, partners, approved perspectives, application link and contact.
- [Structured programme information](/programme.json): The same programme sections in JSON, also used by the browser's read-only WebMCP tools.

## Optional

- [Full text alias](/llms-full.txt): Plain-text version of the complete guide.
- [Privacy policy](https://venusremedies.com/privacypolicy): Venus Remedies privacy policy.